Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke
As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years. We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated. In present study, rats were subjected to...
Gespeichert in:
Veröffentlicht in: | Phytomedicine (Stuttgart) 2018-05, Vol.44, p.20-31 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 31 |
---|---|
container_issue | |
container_start_page | 20 |
container_title | Phytomedicine (Stuttgart) |
container_volume | 44 |
creator | Liu, Bowen Luo, Cheng Zheng, Zhaoguang Xia, Zhenyan Zhang, Qian Ke, Chienchih Liu, Renshyan Zhao, Yonghua |
description | As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years.
We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated.
In present study, rats were subjected to permanent middle cerebral artery occlusion model (MCAo) and were treated with low, middle and high doses of SSS extraction. We assessed neurological function and survival rate, and measured infarct volume by 2,3,5-triphenyltetrazolium chloride staining on day 7 after ischemia. von Willebrand factor (vWF), stromal cell-derived factor-1 alpha (SDF-1α) /chemokine (C-X-C motif) receptor 4 (CXCR4) axis, vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) as well as protein kinase B (AKT)/mammalian target of rapamycin (mTOR) /hypoxia-inducible factor-1 alpha (HIF-1α), extracellular signal-regulated kinase 1/2 (ERK1/2) and Notch1 signaling pathways were respectively investigated by immunofluorescence assay or western blotting in vivo and oxygen–glucose-deprived (OGD) brain microvascular endothelial cells (BMECs); simultaneously, wound healing of BMECs and tube formation assay were administrated.
Compared to MCAo group, SSS extraction could significantly improve neurological functional scores, survival rate and cerebral infarct volume, enhance vWF+ vascular density and perimeter, SDF-1α/CXCR4 axis, VEGF expression, as well as activate AKT/mTOR/HIF-1α and ERK1/2 and inhibit Notch1 pathways in penumbra. In vitro, containing SSS extraction serum increased BMEC migration, capillary formation and VEGF expression via up-regulations of AKT/mTOR and ERK1/2 pathways in OGD BMECs, but ERK inhibitor (U0126) reversed the result of VEGF expression in high dose of SSS group. Additionally, VEGFR2 and Notch1 expressions were suppressed by containing SSS extraction serum. All results were in dose dependent manner.
Our study firstly demonstrates that SSS extraction is an angiogenic switch. Due to suppressed VEGFR2/Notch1 cascades and activated AKT/mTOR and ERK1/2 signals in BMECs, a feedback loop of angiogenic homeostasis is established. Furthermore, the comprehensive mediations of SDF-1α/CXCR4 axis, AKT/mTOR/HIF-α, ERK1/2 and Notch1 pathways in penumbra contribute to the improvements of neurological function, survival rate and infarct volume post-stroke.
[Display omitted] |
doi_str_mv | 10.1016/j.phymed.2018.04.025 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2054965356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0944711318301259</els_id><sourcerecordid>2054965356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-7e26291c01761f4b9694ffe9afc65064faf9f07cb2e6061841ea479a7e6655113</originalsourceid><addsrcrecordid>eNp9kcFu3CAQhlHVqNmmfYOq4thD7QUW8HKpFEVpEiVqpGQr9YZYdrDZ2mYDdpJ9hz50sDa59sQIvvln-H-EvlBSUkLlfFvumn0Hm5IRuiwJLwkT79CMSrosiBJ_3qMZUZwXFaWLY_QxpS0hlKuKfEDHTC2V4Es1Q__uG-jr0eN706epnAoMz0M0dvChxz7hfGH62ocaem9xevKDbfCjNzhCPbZmwhIODp9er-bd6vbuOz6_u6Zzlrs2-FfINMXJ171p8c4MzZPZZ003QMzitoFuEh1i-Auf0JEzbYLPr-cJ-v3zfHV2WdzcXlydnd4UdiHZUFTAJFPUElpJ6vhaScWdA2WclYJI7oxTjlR2zUCSbAenYHilTAVSCpHtOEHfDrq7GB5GSIPu8ibQtqaHMCbNiOBKioWQGeUH1MaQUgSnd9F3Ju41JXrKQW_1IQc95aAJ1zmH3Pb1dcK4nt7emt6Mz8CPAwD5n48eok7WQ29h4yPYQW-C__-EFzrHm5k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2054965356</pqid></control><display><type>article</type><title>Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Liu, Bowen ; Luo, Cheng ; Zheng, Zhaoguang ; Xia, Zhenyan ; Zhang, Qian ; Ke, Chienchih ; Liu, Renshyan ; Zhao, Yonghua</creator><creatorcontrib>Liu, Bowen ; Luo, Cheng ; Zheng, Zhaoguang ; Xia, Zhenyan ; Zhang, Qian ; Ke, Chienchih ; Liu, Renshyan ; Zhao, Yonghua</creatorcontrib><description>As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years.
We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated.
In present study, rats were subjected to permanent middle cerebral artery occlusion model (MCAo) and were treated with low, middle and high doses of SSS extraction. We assessed neurological function and survival rate, and measured infarct volume by 2,3,5-triphenyltetrazolium chloride staining on day 7 after ischemia. von Willebrand factor (vWF), stromal cell-derived factor-1 alpha (SDF-1α) /chemokine (C-X-C motif) receptor 4 (CXCR4) axis, vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) as well as protein kinase B (AKT)/mammalian target of rapamycin (mTOR) /hypoxia-inducible factor-1 alpha (HIF-1α), extracellular signal-regulated kinase 1/2 (ERK1/2) and Notch1 signaling pathways were respectively investigated by immunofluorescence assay or western blotting in vivo and oxygen–glucose-deprived (OGD) brain microvascular endothelial cells (BMECs); simultaneously, wound healing of BMECs and tube formation assay were administrated.
Compared to MCAo group, SSS extraction could significantly improve neurological functional scores, survival rate and cerebral infarct volume, enhance vWF+ vascular density and perimeter, SDF-1α/CXCR4 axis, VEGF expression, as well as activate AKT/mTOR/HIF-1α and ERK1/2 and inhibit Notch1 pathways in penumbra. In vitro, containing SSS extraction serum increased BMEC migration, capillary formation and VEGF expression via up-regulations of AKT/mTOR and ERK1/2 pathways in OGD BMECs, but ERK inhibitor (U0126) reversed the result of VEGF expression in high dose of SSS group. Additionally, VEGFR2 and Notch1 expressions were suppressed by containing SSS extraction serum. All results were in dose dependent manner.
Our study firstly demonstrates that SSS extraction is an angiogenic switch. Due to suppressed VEGFR2/Notch1 cascades and activated AKT/mTOR and ERK1/2 signals in BMECs, a feedback loop of angiogenic homeostasis is established. Furthermore, the comprehensive mediations of SDF-1α/CXCR4 axis, AKT/mTOR/HIF-α, ERK1/2 and Notch1 pathways in penumbra contribute to the improvements of neurological function, survival rate and infarct volume post-stroke.
[Display omitted]</description><identifier>ISSN: 0944-7113</identifier><identifier>EISSN: 1618-095X</identifier><identifier>DOI: 10.1016/j.phymed.2018.04.025</identifier><identifier>PMID: 29895489</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Angiogenesis ; Animals ; Brain Ischemia - drug therapy ; Brain Ischemia - metabolism ; Cells, Cultured ; Chemokine CXCL12 - metabolism ; Disease Models, Animal ; Drugs, Chinese Herbal - chemistry ; Drugs, Chinese Herbal - pharmacology ; Endothelium, Vascular - cytology ; Homeostasis ; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism ; Infarction, Middle Cerebral Artery ; Ischemic stroke ; Mitogen-Activated Protein Kinase 3 - metabolism ; Mitogen-Activated Protein Kinases - metabolism ; Neovascularization, Physiologic - drug effects ; Proto-Oncogene Proteins c-akt - metabolism ; Rats ; Receptor, Notch1 - metabolism ; Receptors, CXCR4 - metabolism ; Shengui Sansheng San ; Stroke - drug therapy ; Stroke - metabolism ; TOR Serine-Threonine Kinases - metabolism ; Vascular Endothelial Growth Factor Receptor-2 - metabolism</subject><ispartof>Phytomedicine (Stuttgart), 2018-05, Vol.44, p.20-31</ispartof><rights>2018 Elsevier GmbH</rights><rights>Copyright © 2018 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-7e26291c01761f4b9694ffe9afc65064faf9f07cb2e6061841ea479a7e6655113</citedby><cites>FETCH-LOGICAL-c362t-7e26291c01761f4b9694ffe9afc65064faf9f07cb2e6061841ea479a7e6655113</cites><orcidid>0000-0002-0644-4687</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.phymed.2018.04.025$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29895489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Bowen</creatorcontrib><creatorcontrib>Luo, Cheng</creatorcontrib><creatorcontrib>Zheng, Zhaoguang</creatorcontrib><creatorcontrib>Xia, Zhenyan</creatorcontrib><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Ke, Chienchih</creatorcontrib><creatorcontrib>Liu, Renshyan</creatorcontrib><creatorcontrib>Zhao, Yonghua</creatorcontrib><title>Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke</title><title>Phytomedicine (Stuttgart)</title><addtitle>Phytomedicine</addtitle><description>As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years.
We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated.
In present study, rats were subjected to permanent middle cerebral artery occlusion model (MCAo) and were treated with low, middle and high doses of SSS extraction. We assessed neurological function and survival rate, and measured infarct volume by 2,3,5-triphenyltetrazolium chloride staining on day 7 after ischemia. von Willebrand factor (vWF), stromal cell-derived factor-1 alpha (SDF-1α) /chemokine (C-X-C motif) receptor 4 (CXCR4) axis, vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) as well as protein kinase B (AKT)/mammalian target of rapamycin (mTOR) /hypoxia-inducible factor-1 alpha (HIF-1α), extracellular signal-regulated kinase 1/2 (ERK1/2) and Notch1 signaling pathways were respectively investigated by immunofluorescence assay or western blotting in vivo and oxygen–glucose-deprived (OGD) brain microvascular endothelial cells (BMECs); simultaneously, wound healing of BMECs and tube formation assay were administrated.
Compared to MCAo group, SSS extraction could significantly improve neurological functional scores, survival rate and cerebral infarct volume, enhance vWF+ vascular density and perimeter, SDF-1α/CXCR4 axis, VEGF expression, as well as activate AKT/mTOR/HIF-1α and ERK1/2 and inhibit Notch1 pathways in penumbra. In vitro, containing SSS extraction serum increased BMEC migration, capillary formation and VEGF expression via up-regulations of AKT/mTOR and ERK1/2 pathways in OGD BMECs, but ERK inhibitor (U0126) reversed the result of VEGF expression in high dose of SSS group. Additionally, VEGFR2 and Notch1 expressions were suppressed by containing SSS extraction serum. All results were in dose dependent manner.
Our study firstly demonstrates that SSS extraction is an angiogenic switch. Due to suppressed VEGFR2/Notch1 cascades and activated AKT/mTOR and ERK1/2 signals in BMECs, a feedback loop of angiogenic homeostasis is established. Furthermore, the comprehensive mediations of SDF-1α/CXCR4 axis, AKT/mTOR/HIF-α, ERK1/2 and Notch1 pathways in penumbra contribute to the improvements of neurological function, survival rate and infarct volume post-stroke.
[Display omitted]</description><subject>Angiogenesis</subject><subject>Animals</subject><subject>Brain Ischemia - drug therapy</subject><subject>Brain Ischemia - metabolism</subject><subject>Cells, Cultured</subject><subject>Chemokine CXCL12 - metabolism</subject><subject>Disease Models, Animal</subject><subject>Drugs, Chinese Herbal - chemistry</subject><subject>Drugs, Chinese Herbal - pharmacology</subject><subject>Endothelium, Vascular - cytology</subject><subject>Homeostasis</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</subject><subject>Infarction, Middle Cerebral Artery</subject><subject>Ischemic stroke</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Rats</subject><subject>Receptor, Notch1 - metabolism</subject><subject>Receptors, CXCR4 - metabolism</subject><subject>Shengui Sansheng San</subject><subject>Stroke - drug therapy</subject><subject>Stroke - metabolism</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><subject>Vascular Endothelial Growth Factor Receptor-2 - metabolism</subject><issn>0944-7113</issn><issn>1618-095X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu3CAQhlHVqNmmfYOq4thD7QUW8HKpFEVpEiVqpGQr9YZYdrDZ2mYDdpJ9hz50sDa59sQIvvln-H-EvlBSUkLlfFvumn0Hm5IRuiwJLwkT79CMSrosiBJ_3qMZUZwXFaWLY_QxpS0hlKuKfEDHTC2V4Es1Q__uG-jr0eN706epnAoMz0M0dvChxz7hfGH62ocaem9xevKDbfCjNzhCPbZmwhIODp9er-bd6vbuOz6_u6Zzlrs2-FfINMXJ171p8c4MzZPZZ003QMzitoFuEh1i-Auf0JEzbYLPr-cJ-v3zfHV2WdzcXlydnd4UdiHZUFTAJFPUElpJ6vhaScWdA2WclYJI7oxTjlR2zUCSbAenYHilTAVSCpHtOEHfDrq7GB5GSIPu8ibQtqaHMCbNiOBKioWQGeUH1MaQUgSnd9F3Ju41JXrKQW_1IQc95aAJ1zmH3Pb1dcK4nt7emt6Mz8CPAwD5n48eok7WQ29h4yPYQW-C__-EFzrHm5k</recordid><startdate>20180515</startdate><enddate>20180515</enddate><creator>Liu, Bowen</creator><creator>Luo, Cheng</creator><creator>Zheng, Zhaoguang</creator><creator>Xia, Zhenyan</creator><creator>Zhang, Qian</creator><creator>Ke, Chienchih</creator><creator>Liu, Renshyan</creator><creator>Zhao, Yonghua</creator><general>Elsevier GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0644-4687</orcidid></search><sort><creationdate>20180515</creationdate><title>Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke</title><author>Liu, Bowen ; Luo, Cheng ; Zheng, Zhaoguang ; Xia, Zhenyan ; Zhang, Qian ; Ke, Chienchih ; Liu, Renshyan ; Zhao, Yonghua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-7e26291c01761f4b9694ffe9afc65064faf9f07cb2e6061841ea479a7e6655113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Angiogenesis</topic><topic>Animals</topic><topic>Brain Ischemia - drug therapy</topic><topic>Brain Ischemia - metabolism</topic><topic>Cells, Cultured</topic><topic>Chemokine CXCL12 - metabolism</topic><topic>Disease Models, Animal</topic><topic>Drugs, Chinese Herbal - chemistry</topic><topic>Drugs, Chinese Herbal - pharmacology</topic><topic>Endothelium, Vascular - cytology</topic><topic>Homeostasis</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</topic><topic>Infarction, Middle Cerebral Artery</topic><topic>Ischemic stroke</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Rats</topic><topic>Receptor, Notch1 - metabolism</topic><topic>Receptors, CXCR4 - metabolism</topic><topic>Shengui Sansheng San</topic><topic>Stroke - drug therapy</topic><topic>Stroke - metabolism</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><topic>Vascular Endothelial Growth Factor Receptor-2 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Bowen</creatorcontrib><creatorcontrib>Luo, Cheng</creatorcontrib><creatorcontrib>Zheng, Zhaoguang</creatorcontrib><creatorcontrib>Xia, Zhenyan</creatorcontrib><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Ke, Chienchih</creatorcontrib><creatorcontrib>Liu, Renshyan</creatorcontrib><creatorcontrib>Zhao, Yonghua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Phytomedicine (Stuttgart)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Bowen</au><au>Luo, Cheng</au><au>Zheng, Zhaoguang</au><au>Xia, Zhenyan</au><au>Zhang, Qian</au><au>Ke, Chienchih</au><au>Liu, Renshyan</au><au>Zhao, Yonghua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke</atitle><jtitle>Phytomedicine (Stuttgart)</jtitle><addtitle>Phytomedicine</addtitle><date>2018-05-15</date><risdate>2018</risdate><volume>44</volume><spage>20</spage><epage>31</epage><pages>20-31</pages><issn>0944-7113</issn><eissn>1618-095X</eissn><abstract>As a traditional Chinese herbal formula, Shengui Sansheng San (SSS) has been employed for stroke treatment more than 300 years.
We hypothesize that SSS extraction is an angiogenic switch in penumbra post-stroke, and corresponding mechanisms are investigated.
In present study, rats were subjected to permanent middle cerebral artery occlusion model (MCAo) and were treated with low, middle and high doses of SSS extraction. We assessed neurological function and survival rate, and measured infarct volume by 2,3,5-triphenyltetrazolium chloride staining on day 7 after ischemia. von Willebrand factor (vWF), stromal cell-derived factor-1 alpha (SDF-1α) /chemokine (C-X-C motif) receptor 4 (CXCR4) axis, vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) as well as protein kinase B (AKT)/mammalian target of rapamycin (mTOR) /hypoxia-inducible factor-1 alpha (HIF-1α), extracellular signal-regulated kinase 1/2 (ERK1/2) and Notch1 signaling pathways were respectively investigated by immunofluorescence assay or western blotting in vivo and oxygen–glucose-deprived (OGD) brain microvascular endothelial cells (BMECs); simultaneously, wound healing of BMECs and tube formation assay were administrated.
Compared to MCAo group, SSS extraction could significantly improve neurological functional scores, survival rate and cerebral infarct volume, enhance vWF+ vascular density and perimeter, SDF-1α/CXCR4 axis, VEGF expression, as well as activate AKT/mTOR/HIF-1α and ERK1/2 and inhibit Notch1 pathways in penumbra. In vitro, containing SSS extraction serum increased BMEC migration, capillary formation and VEGF expression via up-regulations of AKT/mTOR and ERK1/2 pathways in OGD BMECs, but ERK inhibitor (U0126) reversed the result of VEGF expression in high dose of SSS group. Additionally, VEGFR2 and Notch1 expressions were suppressed by containing SSS extraction serum. All results were in dose dependent manner.
Our study firstly demonstrates that SSS extraction is an angiogenic switch. Due to suppressed VEGFR2/Notch1 cascades and activated AKT/mTOR and ERK1/2 signals in BMECs, a feedback loop of angiogenic homeostasis is established. Furthermore, the comprehensive mediations of SDF-1α/CXCR4 axis, AKT/mTOR/HIF-α, ERK1/2 and Notch1 pathways in penumbra contribute to the improvements of neurological function, survival rate and infarct volume post-stroke.
[Display omitted]</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>29895489</pmid><doi>10.1016/j.phymed.2018.04.025</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0644-4687</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0944-7113 |
ispartof | Phytomedicine (Stuttgart), 2018-05, Vol.44, p.20-31 |
issn | 0944-7113 1618-095X |
language | eng |
recordid | cdi_proquest_miscellaneous_2054965356 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Angiogenesis Animals Brain Ischemia - drug therapy Brain Ischemia - metabolism Cells, Cultured Chemokine CXCL12 - metabolism Disease Models, Animal Drugs, Chinese Herbal - chemistry Drugs, Chinese Herbal - pharmacology Endothelium, Vascular - cytology Homeostasis Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Infarction, Middle Cerebral Artery Ischemic stroke Mitogen-Activated Protein Kinase 3 - metabolism Mitogen-Activated Protein Kinases - metabolism Neovascularization, Physiologic - drug effects Proto-Oncogene Proteins c-akt - metabolism Rats Receptor, Notch1 - metabolism Receptors, CXCR4 - metabolism Shengui Sansheng San Stroke - drug therapy Stroke - metabolism TOR Serine-Threonine Kinases - metabolism Vascular Endothelial Growth Factor Receptor-2 - metabolism |
title | Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A24%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Shengui%20Sansheng%20San%20extraction%20is%20an%20angiogenic%20switch%20via%20regulations%20of%20AKT/mTOR,%20ERK1/2%20and%20Notch1%20signal%20pathways%20after%20ischemic%20stroke&rft.jtitle=Phytomedicine%20(Stuttgart)&rft.au=Liu,%20Bowen&rft.date=2018-05-15&rft.volume=44&rft.spage=20&rft.epage=31&rft.pages=20-31&rft.issn=0944-7113&rft.eissn=1618-095X&rft_id=info:doi/10.1016/j.phymed.2018.04.025&rft_dat=%3Cproquest_cross%3E2054965356%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2054965356&rft_id=info:pmid/29895489&rft_els_id=S0944711318301259&rfr_iscdi=true |